CIK: 1565832 - Address: C/O Relmada Therapeutics, Inc., 2222 Ponce De Leon Blvd, 3Rd Floor, Coral Gables, FL 33134
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret11103-10-15-430-16
P%wins10010000040

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/11/24 17:47
9/9/24
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioFLDOCEOP.m3952.82014057384D
1/31/24 18:29
1/29/24
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioFLDOCEOP.m3873.87010069244D
12/12/22 20:00
12/8/22
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioFLDOCEOP1162.1005562144D
7/5/22 16:30
6/30/22
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioFLDOCEOM.dm47616.000305089D
7/5/22 16:30
6/30/22
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioFLDOCEOS.dm-56018.800-30-2589D
3/11/21 17:51
3/9/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d323.240101389D
3/11/21 17:51
3/9/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOS.dm-35535.480-10-1089D
2/26/21 16:50
2/24/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d323.240101389D
2/26/21 16:50
2/24/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOS.d-34234.240-10-1089D
2/16/21 17:10
2/11/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d53.2401289D
2/16/21 17:10
2/11/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOS.d-5135.430-1-289D
2/10/21 19:25
2/8/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d363.240111489D
2/10/21 19:25
2/8/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOS.dm-39435.170-11-1189D
2/4/21 17:42
2/2/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d433.240131889D
2/4/21 17:40
2/2/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d113.2403489D
2/4/21 17:40
2/2/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOS.dm-11535.070-3-489D
1/29/21 17:22
1/27/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d323.240101575D
1/29/21 17:22
1/27/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOS.d-32432.390-10-1275D
1/26/21 19:29
1/22/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d133.2404675D
1/26/21 19:29
1/22/21
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOS.dm-14435.430-4-575D
8/19/20 16:15
8/18/20
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOM.d1623.2405019675D
4/18/16 17:24
4/14/16
ATNMActinium Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsTraversa SergioNYDP.dm62.0213New3D-83-38-10-4-1-1-1-103-10-15-43
12/17/15 09:36
12/15/15
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOP583.050196339D
12/16/15 16:25
12/14/15
RLMDRelmada Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsTraversa SergioNYDOCEOP02.97000320D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact